Chronic Schizophrenia Completed Phase Trials for Galantamine (DB00674)

Also known as: Chronic schizophrenia (disorder) / Schizophrenia, unspecified / Schizophrenia NOS / Dementia praecox / Schizophrenic disorders (disorder) / Unspecified schizophrenia / Unspecified schizophrenia, unspecified state / Schizophrenia / Schizophrenia (disorder)

IndicationStatusPhase
DBCOND0031717 (Chronic Schizophrenia)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00161044An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit SymptomsTreatment